Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
JAMA Oncology|September 13, 2019
Global Variation in Opioid Use in Prostate Cancer TrialsJessica K Roydhouse, Daniel L Suzman, Laurel A Menapace, et al.
Blood Advances|January 28, 2020
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion supportStella T Chou, Mouaz Alsawas, Ross M Fasano, et al.
Trials|August 26, 2015
Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trialJo Howard, Baba Inusa, Christina Liossi, et al.
Annals of Human Genetics|July 30, 2014
Global genetic architecture of an erythroid quantitative trait locus, HMIP-2Stephan Menzel, Helen Rooks, Diana Zelenika, et al.
Blood. Red Cells & Iron|March 11, 2026
Long-term mitapivat treatment is safe and efficacious in patients with sickle cell diseaseAnna Conrey, Nancy Asomaning, Ingrid Frey, et al.
Plos One|August 13, 2013
Genome wide association analysis of a founder population identified TAF3 as a gene for MCHC in humansGiorgio Pistis, Shawntel U Okonkwo, Michela Traglia, et al.
Hemasphere|April 16, 2026
Lower efficacy of transfusion of red blood cells from donors with sickle cell traitMonika Dzieciatkowska, Daniel Stephenson, Ariel Hay, et al.
Blood Advances|February 14, 2018
<i>g(HbF)</i>: a genetic model of fetal hemoglobin in sickle cell diseaseKate Gardner, Tony Fulford, Nicholas Silver, et al.
Blood Advances|December 6, 2024
Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management, in people with hemophilia A or BSteven W Pipe, Toshko Lissitchkov, Pencho Georgiev, et al.
BMC Hematology|November 22, 2018
A ten year review of the sickle cell program in Muhimbili National Hospital, TanzaniaJulie Makani, Furahini Tluway, Abel Makubi, et al.
Pageof 18